Call Options

22 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$0.6 - $1.53 $7,680 - $19,584
12,800 Added 12.74%
113,300 $67,000
Q2 2023

Aug 23, 2023

SELL
$1.05 - $1.63 $6,615 - $10,269
-6,300 Reduced 5.9%
100,500 $113,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $108,240 - $246,246
-90,200 Reduced 45.79%
106,800 $131,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $108,072 - $228,152
-63,200 Reduced 24.29%
197,000 $366,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $494,380 - $2.25 Million
260,200 New
260,200 $622,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $402,783 - $1.7 Million
-189,100 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $56,520 - $140,310
-9,000 Reduced 4.54%
189,100 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $161,700 - $315,370
11,000 Added 5.88%
198,100 $3.1 Million
Q3 2021

Nov 12, 2021

BUY
$24.31 - $33.6 $940,797 - $1.3 Million
38,700 Added 26.08%
187,100 $5.32 Million
Q2 2021

Aug 06, 2021

SELL
$26.09 - $40.4 $487,883 - $755,480
-18,700 Reduced 11.19%
148,400 $5.06 Million
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $2.8 Million - $4.82 Million
-84,600 Reduced 33.61%
167,100 $5.9 Million
Q4 2020

Feb 12, 2021

BUY
$39.09 - $57.4 $9.84 Million - $14.4 Million
251,700 New
251,700 $11.1 Million
Q2 2020

Aug 13, 2020

SELL
$11.71 - $30.29 $1.72 Million - $4.44 Million
-146,500 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$7.64 - $27.5 $111,544 - $401,500
-14,600 Reduced 9.06%
146,500 $2.08 Million
Q4 2019

Feb 12, 2020

SELL
$15.02 - $20.57 $884,678 - $1.21 Million
-58,900 Reduced 26.77%
161,100 $2.49 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $4.15 Million - $6.05 Million
220,000 New
220,000 $4.15 Million
Q2 2019

Aug 20, 2019

SELL
$17.37 - $26.27 $1.22 Million - $1.85 Million
-70,300 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $386,595 - $934,725
36,300 Added 106.76%
70,300 $1.65 Million
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $132,418 - $234,234
-14,300 Reduced 29.61%
34,000 $346,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $76,908 - $186,762
10,200 Added 26.77%
48,300 $808,000
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $87,234 - $186,930
18,600 Added 95.38%
38,100 $179,000
Q3 2017

Nov 15, 2017

BUY
$8.89 - $10.4 $173,355 - $202,800
19,500
19,500 $183,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.